Cargando…
The Relationship Between Metformin and Serum Prostate‐Specific Antigen Levels
BACKGROUND: Metformin is the first‐line oral antihyperglycemic of choice for individuals with type 2 diabetes. Recent evidence supports a role for metformin in prostate cancer chemoprotection. However, whether metformin indeed influences prostate biology is unknown. We aimed to study the association...
Autores principales: | Jayalath, Viranda H., Ireland, Christopher, Fleshner, Neil E., Hamilton, Robert J., Jenkins, David J.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053259/ https://www.ncbi.nlm.nih.gov/pubmed/27403913 http://dx.doi.org/10.1002/pros.23228 |
Ejemplares similares
-
Statin Use and Survival Among Men Receiving Androgen-Ablative Therapies for Advanced Prostate Cancer: A Systematic Review and Meta-analysis
por: Jayalath, Viranda H., et al.
Publicado: (2022) -
Impact of metformin on serum prostate-specific antigen levels: Data from the national health and nutrition examination survey 2007 to 2008
por: Park, Jee Soo, et al.
Publicado: (2017) -
Relationship between serum prostate-specific antigen and age in
cadavers
por: Tsuboi, Hajime, et al.
Publicado: (2020) -
The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen levels.
por: Cote, R. J., et al.
Publicado: (1998) -
Potential role for metformin in urologic oncology
por: Sayyid, Rashid Khalid, et al.
Publicado: (2016)